Selecting the most appropriate end points for clinical trials is important to assess the value of
new treatment strategies. Well-established end points for clinical research exist in oncology …

Purpose Studies have shown an association between socioeconomic status (SES) and
quality of oncology care, but less is known about the impact of patient SES on clinical trial …

Despite all efforts at management, prognosis of advanced lung cancer is extremely poor,
with a median survival time of~ 1 year. The number of cancer patients aged> 70 years is …

Adults aged 65 years or older have been routinely and systematically excluded from
research. With the number of older adults at a record high and growing faster than any other …

Glioblastomas (GBMs) are invariably associated with unavoidable tumor recurrence and
overall poor prognosis. The present study is to summarize the results of clinical Phase III …

Introduction Elderly patients constitute the majority of patients with advanced non–small-cell
lung cancer (NSCLC). The median age of newly diagnosed patients with lung cancer in the …

BACKGROUND: The last decade there has been an increased awareness of the problem of
anastomotic leakage after low anterior resection for rectal cancer, which may have led to …

BACKGROUND: The incidence of colon cancer increases with age, and colon cancer
predominantly affects individuals> 65 years old. However, there are limited data regarding …

BACKGROUND. Disparity in resection rates for malignant brain tumors in elderly patients is
partially attributed to a belief that advanced age is associated with an increased risk of …

Purpose Little is known about the influence of socioeconomic factors on patient access to
cancer trials. Differences should be considered to ensure generalizability of trial results and …